The onset of Alzheimer's disease (AD) is associated with subtle pathological changes including increased intracellular expression of amyloid-β (Aβ). A structure affected particularly early in the course of AD is the entorhinal cortex, where neuronal death in layer II is observed already at initial stages. Neurons in EC-layer II, particularly those that express the protein Reelin, give rise to projections to the hippocampal dentate gyrus and this projection shows severe loss of synaptic contacts during early-stage AD. Given this anatomical specificity, we sought to determine whether increased intracellular expression of Aβ is selectively associated with Reelin-immunoreactive neurons in layer II of the entorhinal cortex. Here we report that in a transgenic rat model, which mimics the onset and distribution of extracellular amyloid deposits seen in human AD subjects, expression of intracellular Aβ in entorhinal layer II selectively occurs in Reelin-immunoreactive neurons during the early, pre-plaque stage. This Reelin-Aβ association is also present in human subjects with AD-related pathological changes, even in early disease stages. These findings strongly indicate that Reelin-immunoreactive neurons in entorhinal layer II play a crucial role during the initial stages of AD, and may therefore lead to refined hypotheses concerning the origin of this devastating condition.
Introduction
Alzheimer's disease (AD) causes progressive cognitive impairment with loss of explicit memory, as measured with cued recall, as one of the most characteristic early features (Dubois et al., 2014) . The ADbrain contains characteristic pathological changes which include abundant extra-cellular amyloid deposits, called plaques, a multitude of neurofibrillary tangles and massive neuronal loss (Duyckaerts et al., 2009) . Importantly, the pathology is not indiscriminately present throughout the brain, such that associational cortical areas, in particular in the temporal lobes are particularly affected (Braak and Braak, 1991; Hyman and Trojanowski, 1997) . This points to regional differences in vulnerability to underlying disease-mechanisms.
A potential key player in AD is amyloid-β (Aβ). This small aggregation-prone peptide, ranging in size from 37 to 43 amino acids, originates from sequential cleavage of the amyloid precursor protein (APP) by β-and γ-secretase. In its fibrillar, insoluble form, Aβ is a major constituent of the extracellular plaques associated with later disease stages (Thal et al., 2000) . Inside neurons, the amount of soluble Aβ is already increased at early, prodromal stages of the disease (D'Andrea et al., 2001; Fernandez-Vizarra et al., 2004; Gouras et al., 2000 Gouras et al., , 2010 Pensalfini et al., 2014) . The correlation between the amount of amyloid deposits with cognitive decline appears weak (Arriagada et al., 1992) . In contrast, the expression of soluble intracellular Aβ (iAβ) in the cortex correlates well with dementia status (McLean et al., 1999; Naslund et al., 2000) . The latter finding is corroborated by reports that in transgenic animal models memory deficits are present when iAβ but no extracellular Aβ is detectable (Billings et al., 2005; Iulita et al., 2014; Knobloch et al., 2007; Leon et al., 2010) . Also, clearance of iAβ reverses memory impairments (Billings et al., 2005) , and increased amounts of iAβ correlate well with neuronal loss (Casas et al., 2004; Cohen et al., 2013; Umeda et al., 2011) . A direct link to impaired neuronal functioning has also been found, as soluble Aβ disrupts synaptic plasticity and inhibits long-term potentiation both in vitro (Lambert et al., 1998) and in vivo (Walsh et al., 2002) . Finally, in a 3D cell-culture system harboring neurons transfected with familial AD mutations, Aβ-accumulation reversibly induces hyperphosphorylation and aggregation of tau (Choi et al., 2014) . Taken together, soluble iAβ thus seems to be a key player in the initiation of the disease-cascade which eventually culminates in the characteristic pathological and cognitive changes seen in AD.
The seminal histopathological study on AD by Braak and Braak (1991) revealed that initial changes related to formation of neurofibrillary tangles occur in layer II of lateral parts of the entorhinal cortex (EC) at the border with the perirhinal cortex. It has since been established that EC is also subject to extracellular amyloid depositions from an early stage of the disease (Thal et al., 2000) . Further, massive neuronal loss in EC-layer II characterizes early AD (Gomez-Isla et al., 1996) , a feature also evident in at least a subset of subjects with mild cognitive impairment (Kordower et al., 2001) , of which the majority are likely to convert to AD (Espinosa et al., 2013; Grundman et al., 2004) . Clearly, these findings implicate EC, and particularly the neurons in layer II, in the onset of AD.
Neurons in EC-layer II give rise to the main projection to the hippocampal dentate gyrus (DG) and this projection shows severe loss of synaptic contacts during early-stage AD (Scheff et al., 2006) . Many principal neurons in EC-layer II in mammals express Reelin (Chin et al., 2007; Herring et al., 2012; Kitamura et al., 2014; Martinez-Cerdeno et al., 2003; Perez-Garcia et al., 2001; Pesold et al., 1998; Ramos-Moreno et al., 2006) . Such a Reelin-expressing population in superficial layers is atypical for cortex, where Reelin is expressed primarily in a subset of principal cells of layer V (Pesold et al., 1998; Ramos-Moreno et al., 2006) . In rodents, Reelin-expressing neurons in EC-layer II, as established by their Reelin-immunoreactivity (Reelin-IR), form the sole origin of the excitatory projection to DG (Berndtsson, 2013; Gianatti, 2015; Kitamura et al., 2014; Varga et al., 2010) , which is of interest since Reelin is a modulatory protein involved in synaptic plasticity (Qiu et al., 2006; Rogers et al., 2011; Weeber et al., 2002) .
We thus chose to focus on EC and hypothesized that the population of Reelin-IR neurons in layer II is particularly vulnerable to accumulation of iAβ. We utilized the McGill-R-Thy1-APP rat model for AD, which faithfully mimics the onset and distribution of extracellular amyloid deposits seen in human AD subjects, and has an extended phase of iAβ-accumulation (Iulita et al., 2014; Leon et al., 2010) . Our data show that Reelin-IR neurons in EC-layer II selectively stain positive for iAβ during the early, pre-plaque stage. Furthermore, we show that this Reelin-Aβ association is present in human subjects having AD-related pathology, not only in the late stages but also in early stages, suggesting that Reelin-IR neurons in EC-layer II play a crucial role during the initial events leading to AD.
Materials and methods

Experimental design
In this paper we aimed to test whether accumulation of iAβ in EClayer II specifically occurs in Reelin-IR neurons. For the experimental part of this study we used the McGill-R-Thy1-APP homozygous transgenic rat model (Heggland et al., 2015; Leon et al., 2010) . Animals carry a transgene containing human APP751 with the Swedish doubleand Indiana mutations expressed under the murine Thy1.2 promoter. All rats were bred at the Kavli Institute for Systems Neuroscience, at the Norwegian University of Science and Technology. Experimental protocols were approved by the Norwegian Animal Research Authority and are in accordance with the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes. We used 20 animals divided into four age-groups (n = 5/ group), postnatal day 15 (5 males), 1 month (3 males and 2 females), 3 months (3 males and 2 females), and 6 months (3 males and 2 females). To corroborate the findings in the rat model, we used sections through EC from AD-subjects with pathologically verified Braak stages I (female, 83 years old), III (female, 75 years old) and V (male, 66 years old) (Braak and Braak, 1991) . These sections were provided by Professor Ricardo Insausti (University of Castilla-La Mancha, Spain) and originally consisted of three sections from each of three subjects, approximately equally distributed along the anteroposterior extent of EC. After optimization of the staining-protocols we were left with two sections from Braak stage I, and one section from each of stages III and V, on which the double-IHC experiments were carried out. In the case of the two sections for Braak stage I, these were from an anterior and a posterior level, while in the case of Braak stages III and V, the sections were taken at a middle or posterior level, respectively.
Genotyping
The animals were genotyped for the expression of the transgene by quantitative PCR (qPCR), as previously described (Heggland et al., 2015 (Livak and Schmittgen, 2001 ).
Tissue processing and IHC
Animals were anesthetized using isoflurane gas (Abbott Lab., Cat# 05260-05) followed by intraperitoneal injection of pentobarbital (Norwegian Pharmacy Association, Cat# 306498). Subsequently, transcardial perfusion was carried out with a Ringer's Solution (145 mM NaCl, VWR Int. LLC, Cat# 27800.291; 3.35 mM KCl, Millipore, Cat# 1.04936.1000; 2.38 mM NaHCO 3 , Millipore, Cat# 1.06329.1000) at pH 6,9, followed by circulation of 4% freshly depolymerized paraformaldehyde-solution (Millipore, Cat# 1.04005.1000) in phosphate buffer (PB: purified de-ionized water with di-sodium hydrogen phosphate dihydrate, Millipore, Cat# 1.37036.500, mixed with sodium di-hydrogen phosphate monohydrate, Millipore, Cat# 1.06346.1000, at 125 mM, pH 7.6; note that this applies to all uses of PB) for 2-3 min. The brains were removed and post fixed in the same fixative overnight, then placed in 2% DMSO solution (dimethyl sulfoxide, VWR Int. LLC, Cat# 23486.297, in PB and 20% glycerine, VWR, Cat# 24387.292) in a refrigerator until sectioning. Brains were sectioned at 40 μm in the coronal plane with a freezing microtome (Microm HM430, Thermo Fisher Scientific, Waltham, MA, USA). For each animal, we collected six series of equally spaced sections. One series was used (i.e. 40 μm sections with a 200 μm spacing), and immunohistochemistry was done on free-floating sections. Heat Induced Antigen Retrieval was carried out on all tissue at 60°C for 3 h in PB.
Rat tissue
For fluorescent immunolabeling of rat-tissue, blocking with 5% goat serum (Abcam, Cat# AB7481) in PB was carried out for 2 h. For immunoenzyme staining of rat tissue, incubation with ready-to-use hydrogen peroxide (Thermo Scientific, Cat# TA-012-HP) was carried out for 10 min followed by incubation with Ultra V Block (Thermo Scientific, Cat# TA-012-UB) for 10 min and finally incubation with 5% goat serum in PB for 1 h. Subsequently, co-incubation with primary antibodies in PB (for immunofluorescence) or Tris buffered saline (for immunoenzymestaining: TBS; purified de-ionized water with 50 mM Tris, Millipore, Cat# 1.08382; 150 mM NaCL, VWR Int. LLC; pH adjusted to 8.0 using hydrochloric acid, Millipore, Cat# 1.00317), both solutions containing 0.5% Triton X-100 (Millipore, Cat# 1.08603.1000) and 5% goat serum, was carried out in the following order: Rabbit anti-Reelin (1:50 for fluorescence/1:600 for immunoenzyme-staining, Biorbyt, Cat# Orb11331, RRID AB_10750301) with Mouse anti-Aβ McSA1 (1:1000, Medimabs, Inc., Cat# MM0015-P, RRID: AB_1807985); Rabbit anti-Reelin (1:50, Biorbyt) with Mouse anti-Aβ MOAB-2 (1:500, Biosensis, Cat# M-1586-100); Rabbit anti-Reelin (1:50, Biorbyt) with Mouse anti-Reelin G10 (1:500, Millipore, Cat# MAB5364, RRID: AB_2179313); Goat antiReelin (1:200, R&D Systems, Cat# AF3820, RRID AB_2253745) with Mouse anti-Aβ McSA1 (1:1000, Medimabs, Inc.); Mouse anti-Reelin G10 (1:1000, Millipore) with Rabbit anti-Aβ42 (1:500, IBL Ltd., Cat# 18582). For immunofluorescence, secondary antibodies were purchased from Life Technologies and included Alexa 488 Goat anti-Rabbit (Cat# A11008, RRID: AB_10563748), Alexa 546 Goat anti-Mouse (Cat# A11003, RRID: AB_10562732) and Alexa 488 Donkey anti-Goat (Cat# A11055, RRID AB_10564074). For fluorescence, all sections were incubated with secondary antibodies in 1:350 dilution with PB containing 0.5% Triton X-100 and 5% goat serum. Each pair of secondary antibodies was applied simultaneously for 2 h at room temperature, with one exception: in the double-immunofluorescence staining with Goat antiReelin and McSA1 (see Fig. 5B ) the tissue was first incubated with Alexa 488 Donkey anti-Goat for 1 h, then washed, and then incubated with Alexa 546 Goat anti-Mouse for 1 h. For immunoenzyme-staining of rat tissue, we used as secondary antibodies AP-conjugated goat anti-mouse polymer (Biocare, Cat# MALP521L) and HRP-conjugated goat anti-rabbit polymer (Dako, Cat# K4011), both ready-to-use reagents. The secondary antibodies were visualized using enzymatic chromogens, and the incubation was conducted under close visual inspection until a satisfactory color-contrast was achieved. Chromogens included Dako DAB+ (Dako, Cat#K4011) for HRP-conjugated goat antirabbit polymer (dilution according to the manufacturer's instruction, incubation time approximately 10 min) followed by Ferangi Blue (Biocare Medical, Cat# FB813S) for the AP-conjugated goat anti-mouse polymer (dilution 1:300, incubation time approximately 5 min). Processed tissue was mounted on glass slides from a solution of 50 mM tris(hydroxymethyl)aminomethane (Millipore, Cat# 1.08382.1000) with hydrochloric acid, at pH 7.6, containing gelatin (Oxoid, Ltd. Cat# LP0008), and then left to dry overnight before being coverslipped using entellan (Merck KGaA, Cat# 1.07960.0500).
Human tissue
The human-tissue was initially incubated with Dual-Block reagent (Dako Cat# S2003) for 10 min followed by incubation with 10% goat serum in PB for 1 h. Subsequently, co-incubation with primary antibodies in PB containing 0.4% Saponin (VWR, Cat# 27534.187) and 5% goat serum was carried out, using Rabbit anti-Reelin (1:50, Biorbyt) with Mouse anti-Aβ McSA1 (1:150, Medimabs). As secondary antibodies we used AP-conjugated goat anti-mouse polymer (Biocare, Cat# MALP521L) and HRP-conjugated goat anti-rabbit polymer (Dako, Cat# K4011), both ready-to-use reagents. The secondary antibodies were visualized using enzymatic chromogens, and the incubation was conducted under close visual inspection until a satisfactory color-contrast was achieved. Chromogens included AEC (Dako, Cat# K3469) for the HRPconjugated goat anti-rabbit polymer (incubation time approximately 5 min) followed by Ferangi Blue (Biocare Medical) for the AP-conjugated goat anti-mouse polymer (dilution 1:125, incubation time approximately 10 min). Table 1 contains an overview of the primary and secondary antibodies used in this study.
Microscopy and stereology
For the rat model, we randomly selected one of the six series of sections from each brain, such that the full extent of EC was represented for each animal. Layer II of LEC and MEC was delineated in Stereo Investigator (MicroBrightField Inc.) following established criteria (Kjonigsen et al., 2011) under dark field illumination (Axio Imager M1 microscope, Carl Zeiss). Analysis of co-localization was carried out using Stereo Investigator, applying the principles of stereology, which have been described in detail previously (West et al., 1991) . Briefly, using epifluorescence microscopy (Zeiss Axio Imager M1), neurons were identified in a systematically randomized manner by applying a predefined virtual grid where each intersection contains a counting frame. Each neuron contained within a counting frame according to the stereological principles for inclusion was analyzed to determine if it was positive for Reelin and/or iAβ, by focusing through the tissue within a virtual dissector frame using a high power objective (100 × oil, N.A. 1.4). Confocal images were obtained with the use of a Zeiss LSM Meta 510 confocal microscope, using Zen software (Carl Zeiss, Version 6,0,0303) with a 100 × oil immersion objective (N.A. 1.4). Confocal images were subsequently color coded using the lookup table in ImageJ (NIH, Version 1.43 m).
We tested for normality of distribution, homogeneity of variance and a statistical difference in estimated numbers of Reelin-IR neurons between age groups (one-way ANOVA followed by a post hoc Tukey test) using IBM SPSS Statistics (Version 20.0.0.1).
Tissue from human AD-subjects was analyzed for co-localization using brightfield microscopy (Zeiss Axio Imager M1) and focusing through the tissue using a high power objective (100 × oil, N.A. 1.4). As we did not have access to complete series of sections through EC, we analyzed all stained neurons rather than doing a stereological analysis on EC-layer II from the available tissue-samples. Consequently, EClayer II was delineated on each section and all stained neurons were analyzed to determine whether they were positive for Reelin and/or iAβ. Images of human tissue were optimized for color-contrast in ImageJ.
Results
In EC-layer II, iAβ is selectively expressed in Reelin-IR neurons
In the rat transgenic model, immunoenzyme-staining for Reelin and iAβ on separate coronal sections taken from the same level of EC-layer II revealed a highly similar pattern of immunoreactive (IR) neurons for both molecules (Fig. 1A) . To test whether Reelin-IR neurons in EClayer II selectively express iAβ in the transgenic model, we used a double-immunofluorescent staining for both substances, combining a rabbit anti-Reelin antibody with a mouse anti-Aβ (MCSA1) antibody (Fig.  1B) . This corroborated the impression of overlap between the two markers while also showing that irrespective of the rostrocaudal level, Table 1 Overview of primary and secondary antibodies used for rat tissue (top panel) and human tissue (bottom panel). In the case of the rat tissue, corresponding numbers (e.g. 1 and 1′) indicate which primary antibodies were used together in double-labeling experiments shown in the indicated figures. Fig. 8A , B; 5 and 5′ Fig. 5B ; * these antibodies were also used for single labeling, Fig. 1A, C) . Fig. 9A , B.
neurons located closer to the rhinal fissure consistently have stronger iAβ-and Reelin-staining than neurons located progressively further away from the rhinal fissure (Fig. 1B, C) . In the case of Reelin, this feature has also been noted by others (Perez-Garcia et al., 2001) .
To determine the degree of overlap between iAβ-IR and Reelin-IR neurons, we used the double-immunofluorescence staining method and analyzed 5852 neurons in the lateral (LEC) and medial (MEC) subdivisions of EC-layer II (LEC 2114; MEC 3738) from 20 animals divided into four age-groups (P15, 1 month, 3 months and 6 months). The age-groups were selected to start at P15 when adult-like principal neurons are known to be present in EC Witter, 2012a, 2012b) and extending up to and including 6 months, thereby covering the pre-plaque stage in our colony of McGill-R-Thy1-APP rats (Heggland et al., 2015) . With stereological systematic random sampling, we obtained a reliable estimate of the number of layer II Reelin-IR neurons (P15: LEC 34772, MEC 74710; 1 month: LEC 44558, MEC 116613; 3 months: LEC 52124, MEC 111394; 6 months: LEC 40923, MEC 130129). The estimated Reelin-IR neuron numbers were found normally distributed and with homogeneous variance. Analysis of variance followed by post hoc multiple comparison test (Tukey test), conducted separately for LEC and MEC on all age groups, revealed a significantly lower estimate of Reelin-IR neurons in MEC for the P15 group as compared with MEC-estimates in each of the other three age groups (P b 0.05).
In line with our initial observations, the analysis of neurons revealed that iAβ is selectively present in Reelin-IR principal neurons throughout the pre-plaque stage (Fig. 2) . In the P15-group, 98.6% of LEC (437/443) and 98.9% of MEC (616/623) Reelin-IR principal neurons in layer II were positive for iAβ ( Fig. 2A) . For each subsequent age-group we found 100% of Reelin-IR principal neurons in layer II to be immunoreactive for iAβ (Fig. 2B-D) . Further, all obtained data combined (n = 5852 neurons) showed that only 11 iAβ-IR neurons were not immunoreactive for Reelin; these were found in the P15 (N = 4), 3 months (N = 4) and the 6 months group (N = 3). 
Fig. 2. Analysis of double-immunofluorescence staining in EC-layer II of 20 animals revealed that iAβ-IR material is selectively expressed in Reelin-IR neurons (n = 5852 neurons). (A-D)
Representative confocal images of iAβ and Reelin-IR neurons in LEC and MEC from double-immunoreacted sections are displayed for ages P15 (A), one month (B), three months (C) and six months (D). For each age-group the number of EC-layer II Reelin-IR principal neurons analyzed, together with the number of these co-localizing with iAβ is shown (lower left). The estimated total population of Reelin-IR neurons in layer II of LEC vs MEC is shown as well (lower right; mean ± standard deviation; CE = coefficient of error). With exception of 13 neurons in the P15 group, every Reelin-IR principal neuron was found positive for iAβ, and, importantly, for all age-groups combined we observed iAβ outside the Reelin-IR population in only 11 instances. Scale bar, 20 μm. Five animals were used for each age-group.
Control experiments confirm and reinforce iAβ-Reelin association
The observed high incidence of co-localization between Reelin and iAβ is based on fluorescence microscopy of immunoreacted brain sections. This experimental approach suffers from three inherent ways leading to false positive results. First, crosstalk between fluorophores could result if these have overlapping excitation or emission spectra. Second, the rabbit anti-Reelin primary antibody could potentially be unspecific. Third, the mouse anti-Aβ primary antibody (McSA1) could potentially be unspecific. These three possible events were therefore investigated in turn.
For the experiments we used the Alexa 488 dye to image Reelin and the Alexa 546 dye to image iAβ. In order to assess potential spectral bleed-through, we imaged single-immunoreacted sections labeled with either Alexa 488 dye or Alexa 546 dye and compared the emitted signal between the matching and non-matching filters used in our epifluorescence microscope-setup. This procedure revealed no evidence of bleed-through (Fig. 3A) . We further tested for bleed-through using confocal microscopy by scanning double-immunoreacted sections and comparing the emitted signal between the matching and non-matching detection channel for each laser line. Again, we found no evidence of bleed-through between the channels used in our confocal microscopesetup. In these confocal images, we further observed a Reelin-IR neuron negative for iAβ, providing an additional control against bleed-through (Fig. 3B) .
As a control for the double-immunofluorescence method, we performed double-immunoenzyme staining with the same pair of antibodies on sections from 1 and 6 month old transgenic rats vs. controls. This essentially replicated the results of our double-immunofluorescence procedure (Fig 4A, B) .
In order to ensure the specificity of the rabbit anti-Reelin antibody, we compared its immunoreactivity with that of the well-characterized mouse anti-Reelin G10 clone in a double-immunostaining procedure. This revealed a near complete overlap between the two antibodies in EC-layer II (Fig. 5A) . Additionally, we replaced the rabbit anti-Reelin antibody with a goat anti-Reelin antibody and performed double-immunostaining together with McSA1, which corroborated our original results (Fig. 5B) .
As a control for the McSA1 antibody, we replaced it with MOAB-2, an antibody that exclusively binds Aβ-peptides, in particular the Aβ42-form (Youmans et al., 2012) . Double-immunofluorescence staining using MOAB-2 and rabbit anti-Reelin again confirmed our original results, i.e. iAβ was selectively associated with Reelin-IR neurons (Fig. 6) .
Further, MOAB-2 immunolabeling gave an intracellular pattern strikingly similar to that seen in case of Reelin-IR (Fig. 6, insets) . Subsequent confocal microscopy revealed Reelin-IR material partially co-localized with iAβ as detected by McSA1, while a near complete colocalization was observed between Reelin-IR material and iAβ as detected by MOAB-2 (Fig. 7A, B) .
Finally, we used a rabbit C-terminal specific antibody against Aβ42 together with the mouse anti-Reelin G10 clone and performed double-immunoenzyme staining on 6 month old animals. This method revealed strong iAβ42 labeling in EC-layer II Reelin-IR neurons in the rat transgenic model vs. controls (Fig. 8) .
Evidence for iAβ-Reelin association in EC of human AD-cases
We next investigated whether the iAβ-Reelin association directly relates to the etiology of AD in humans, by using the MCSA1 and rabbit anti-Reelin antibodies and analyzing double-immunoreacted samples of EC-tissue from three human subjects with pathologically confirmed AD, including Braak stages I, III and V (Fig. 9A, B) . Out of 3077 layer II neurons immunoreactive for Reelin across all analyzed samples, 2871 neurons were also immunoreactive for iAβ. Only 36 neurons negative Figs. 1 and 2 ). Scale bars, 40 μm. Fig. 6 . Aβ42 (detected with a specific antibody, MOAB-2; Biosensis) is confined to Reelin-IR neurons in EC-layer II. Note the high degree of intracellular overlap between Reelin and MOAB-2 staining. Scale bars, 100 μm, inset 10 μm.
for Reelin were found to contain iAβ (Fig. 9C) . In particular, for Braak stage I, we identified 1631 Reelin-IR neurons in EC-layer II of which 1497 were also iAβ-IR, while 8 Reelin-negative neurons contained iAβ. For Braak stage III, we identified 969 Reelin-IR neurons in EC-layer II of which 950 were also iAβ-IR, while 21 Reelin-negative neurons contained iAβ. For Braak stage V, we identified 441 Reelin-IR neurons in EC-layer II of which 424 were also iAβ-IR, while 7 Reelin-negative neurons contained iAβ.
Discussion
We report that in EC-layer II, Reelin-IR neurons selectively express iAβ during the pre-plaque stage in a transgenic rat model for AD, such that essentially no iAβ is found in layer II neurons that do not express Reelin. Further, we present evidence that this may directly translate to the situation in the human brain during the initial pathological stages of AD. Finally, in the rat model we observe a topographical gradient in EC-layer II, with immunoreactivity for iAβ being strongest in neurons located closest to the rhinal fissure.
Immunolabeling as a means to detect Aβ-peptides requires the use of antibodies that are not confounded by exhibiting cross reactivity to APP or its non-Aβ cleavage fragments. For our experiments we used the extensively tested anti-Aβ antibody MCSA1, which has been shown to exhibit minimal cross reactivity with APP as well as the β Cterminal fragment (β-CTF) (Iulita et al., 2014; Leon et al., 2010) . We subsequently verified the presence of iAβ in EC-layer II Reelin-IR neurons with the MOAB-2 antibody, which binds Aβ-peptides with a strong preference for Aβ42 without any cross reactivity to APP or β-CTF (Youmans et al., 2012) . Finally, we used a C-terminal specific anti-Aβ42 antibody in order to substantiate that elevated levels of Aβ42 is indeed a characteristic of EC-layer II Reelin-IR neurons.
Aβ-peptides have been recognized as important factors in the initiation of AD (Billings et al., 2005; Casas et al., 2004; Choi et al., 2014; Cohen et al., 2013; Iulita et al., 2014; Knobloch et al., 2007; Lambert et al., 1998; Leon et al., 2010; McLean et al., 1999; Naslund et al., 2000; Umeda et al., 2011; Walsh et al., 2002) . Neuronal accumulation of iAβ, in particular Aβ42, is an initial event in AD (D'Andrea et al., 2001; Fernandez-Vizarra et al., 2004; Gouras et al., 2000 Gouras et al., , 2010 Pensalfini et al., 2014) , while EC-layer II has been identified as exhibiting early pathological changes, with neuronal loss evident already at preclinical stages (Braak and Braak, 1991; Gomez-Isla et al., 1996; Kordower et al., 2001) . Our findings in EC-layer II that iAβ is confined to Reelin-IR neurons, and that Aβ42 and Reelin apparently are co-localized within the cells provide a clear indication that Reelin and iAβ could be structurally associated. This is in line with reports that amyloid-peptides and Reelin colocalize in hippocampal amyloid deposits of aged transgenic and wildtype mice (Doehner et al., 2010) and that Reelin extracted from ADbrains consists of various complexes of higher molecular mass instead of the functional homodimers seen in age-matched controls (CuchilloIbáñez et al., 2013) .
Supporting this proposed structural association is a report that in the presence of Aβ42, Reelin fails to form the homodimers, which constitute the active form of Reelin. This results in a reduced ability to activate ApoER2, the main Reelin-receptor in the brain (Cuchillo-Ibáñez et al., 2013) . Aβ-induced impairment of Reelin signaling may influence targets downstream of Reelin-IR neurons. Reelin-IR neurons are the exclusive origin of the excitatory projection from EC-layer II onto the hippocampal DG, as well as to the CA2 and CA3 subdivisions (Berndtsson, 2013; Gianatti, 2015; Kitamura et al., 2014; Varga et al., 2010) . A substantial proportion of non-Reelin positive neurons in layer II have been identified as being immunoreactive for the calcium binding protein calbindin (Naumann et al., 2015; Varga et al., 2010) . Although the functional properties of Reelin positive and calbindin positive neurons in layer II are still enigmatic, it is established that calbindin neurons do not, or sparsely project to HF (Kitamura et al., 2014; Varga et al., 2010) .
Reelin, synthesized in EC-layer II, can be transported to and released at its hippocampal targets in a manner independent of neurotransmitter release (Martinez-Cerdeno et al., 2003) . The significance of this constitutive release is currently not fully understood, but application of Reelin to the bath fluid of hippocampal slices enhanced long-term potentiation in hippocampal neurons (Qiu et al., 2006; Weeber et al., 2002) . Also, injecting Reelin into the ventricles of adult mice resulted in enhanced performance on hippocampus-dependent tasks, and correlated with increased hippocampal dendritic spine density (Rogers et al., 2011) . Since axons from EC-layer II neurons projecting to the hippocampus also give rise to an extensive collateral plexus in layers I and II of EC Witter, 2012a, 2012b) , one may suggest that synaptic alterations similar to those reported in the hippocampus could take place in EC as well. It is important to keep in mind however, that the relationship between Reelin, iAβ, and cognitive functions is not unequivocally established. Nevertheless, if iAβ structurally associates with Reelin in EC-layer II neurons during initial AD-stages, impaired transport of Reelin from these neurons onto their hippocampal synaptic terminals might be expected. In line with this, early (P30) overall loss of Reelin, as measured with western blot, has been reported in the hippocampus of transgenic mice carrying human APP with AD-related mutations. Moreover, in human AD-cases, loss of Reelin was found specifically associated with CA3-CA2 neurites corresponding to terminations from EC-layer II neurons (Herring et al., 2012) .
We observed the strongest iAβ-IR in EC-layer II neurons located in dorsolateral portions of EC, i.e. close to the rhinal fissure. A topologically comparable preferred expression of hyperphosphorylated tau has been found in EC of a transgenic mouse model and in EC of AD-brains (Braak and Braak, 1991; Khan et al., 2014) . In rodents, dorsolateral EC preferentially connects with dorsal parts of the hippocampal formation, while more ventromedial parts of EC connect to ventral parts of the hippocampal formation (Cappaert et al., 2014) . This connectional topography is paralleled by gradual differences in resolution of spatial coding in both structures, such that the level of resolution with which the environment is represented changes along their respective dorsoventral axes. In the rodent hippocampal formation, the size of the specific spatial receptive field of place cells increases along the dorsoventral axis (Jung et al., 1994; Kjelstrup et al., 2008) . A similar spatial granularity gradient exists in EC, where grid cells close to the rhinal fissure have a fine-grained spatial representation, while cells located progressively further away from the rhinal fissure are tuned to increasingly more coarse spatial representations (Brun et al., 2008; Stensola et al., 2012 ). An analogous gradient is present in human hippocampal formation and EC, where the most posterior parts correlate with fine-grained spatial representations, while engagement of anterior parts reflect coarsegrained spatial representations (Evensmoen et al., 2013 (Evensmoen et al., , 2015 . Taken together, these findings logically imply that initial iAβ-induced impairment of entorhinal-hippocampal connectivity is likely to selectively affect functions associated with fine-grained representations of external information. This interpretation concurs with navigational deficits that are already evident in subjects with mild cognitive impairment (Hort et al., 2007; Laczo et al., 2009) , as well as with the recently reported predictive sensitivity of fine grained recall tasks as part of the diagnostic criteria for early diagnosis of AD (Dubois et al., 2014) .
Conclusions
Although we only analyzed a small sample of human AD cases, the consistency of the human observations about the selective presence of iAβ in EC-layer II Reelin-IR neurons is evident, suggesting that this might be a common feature of human AD-pathology. This is supported by the more extensive, consistent rat-model data, where selective presence of iAβ in Reelin-IR neurons in EC-layer II is evident throughout the pre-plaque stage. However, a study on a larger sample of human ADcases is needed in order to substantiate that selective presence of iAβ in Reelin-IR neurons in EC-layer II is indeed a shared feature in AD patients, and whether or not this association in the early stage of the disease selectively occurs in those parts of EC which are adjacent to the rhinal and collateral sulci. If so, this will emphasize that a structural interaction between Reelin and iAβ indeed is a crucial factor in the etiology of AD, forming a signature of early disease-stages. This may lead to refined hypotheses concerning disease-initiating mechanisms and eventually to the development of targeted treatments of AD.
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